company background image
8YY logo

Biolidics Catalist:8YY Stock Report

Last Price

S$0.018

Market Cap

S$30.4m

7D

-10.0%

1Y

50.0%

Updated

19 Apr, 2025

Data

Company Financials

Biolidics Limited

Catalist:8YY Stock Report

Market Cap: S$30.4m

8YY Stock Overview

A precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. More details

8YY fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Makes less than USD$1m in revenue (SGD858K)

Volatile share price over the past 3 months compared to the SG market

+ 1 more risk

Biolidics Limited Competitors

Vicplas International

SGX:569

S$36.3m

Quantum Healthcare

Catalist:V8Y

S$8.0m

Medtecs International

Catalist:546

S$60.5m

UG Healthcare

Catalist:8K7

S$63.0m

Price History & Performance

Summary of share price highs, lows and changes for Biolidics
Historical stock prices
Current Share PriceS$0.018
52 Week HighS$0.033
52 Week LowS$0.008
Beta0.69
1 Month Change-30.77%
3 Month Change-30.77%
1 Year Change50.00%
3 Year Change-85.12%
5 Year Change-96.00%
Change since IPO-92.34%

Recent News & Updates

Recent updates

Shareholder Returns

8YYSG Medical EquipmentSG Market
7D-10.0%0.5%5.1%
1Y50.0%9.1%14.0%

Return vs Industry: 8YY exceeded the SG Medical Equipment industry which returned 9.1% over the past year.

Return vs Market: 8YY exceeded the SG Market which returned 14% over the past year.

Price Volatility

Is 8YY's price volatile compared to industry and market?
8YY volatility
8YY Average Weekly Movement14.0%
Medical Equipment Industry Average Movement4.5%
Market Average Movement5.4%
10% most volatile stocks in SG Market14.6%
10% least volatile stocks in SG Market3.0%

Stable Share Price: 8YY's share price has been volatile over the past 3 months compared to the SG market.

Volatility Over Time: 8YY's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of SG stocks.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

FoundedEmployeesCEOWebsite
20097n/awww.biolidics.com

Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes.

Biolidics Limited Fundamentals Summary

How do Biolidics's earnings and revenue compare to its market cap?
8YY fundamental statistics
Market capS$30.43m
Earnings (TTM)-S$3.19m
Revenue (TTM)S$858.00k

35.5x

P/S Ratio

-9.5x

P/E Ratio

Is 8YY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8YY income statement (TTM)
RevenueS$858.00k
Cost of RevenueS$552.00k
Gross ProfitS$306.00k
Other ExpensesS$3.50m
Earnings-S$3.19m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0019
Gross Margin35.66%
Net Profit Margin-372.03%
Debt/Equity Ratio97.5%

How did 8YY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/19 05:50
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biolidics Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi Sin NgohCGS International